Armetheon logo — San Francisco Bay-based clinical stage biopharmaceutical com...

Armetheon

San Francisco Bay-based clinical stage biopharmaceutical company dedicated to pioneering novel treatments for urgent medical needs.

Founded 2011 11-50 employees Series B Total: $31.30M Biopharma, Biotechnology +1

General Information

Company Name Armetheon
Founded Year 2011
Employees 11-50
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series B
Social

Get notified when Armetheon moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Armetheon

Armetheon is a San Francisco Bay-based clinical stage biopharmaceutical company founded in 2011. Committed to addressing urgent medical needs, the company focuses on pioneering innovative treatments for areas with significant unmet needs. Their dedication has attracted substantial investment, with the latest being a $24.30M Series B investment on 05 February 2015. The investment was made by prominent firms including CDIB Capital, Atheneos Capital, Hercules Bioventure Partners, and Capital TEN. Armetheon has multiple programs in advanced clinical stages, demonstrating their commitment to bringing novel drugs to fruition. As a player in the biopharma, biotechnology, and pharmaceutical industries, Armetheon's work has the potential to make a significant impact on the medical field, offering hope to patients in need.

Taxonomy: Biopharmaceutical, Clinical Stage, Drug Development, Anti-coagulants, Cardiovascular, Research and Development, Clinical Development, Basic Research, Thrombosis, San Francisco Bay, Innovative Drugs, Medical Needs, Urgent Medical Needs, Unmet Needs

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $24.30M 4 Hercules Bioventure Partners, Atheneos Ventures +1 05 Feb 2015
Series A $7.00M 4 Larry Hsu, Hercules Bioventure Partners +2 28 Aug 2014

Armetheon Alternatives & Competitors

Armetheon vs

Creating Value Through China's Specialty Pharmaceuticals Market

Series D
8 employees
Biopharma, Biotechnology
Armetheon vs
KBP Biosciences
KBP Biosciences United States

At KBP we are consistently reminded that patient care is the end goal of what we do daily.

Series A
40 employees
Biotechnology, Health Care
Armetheon vs

Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and...

Post Ipo Equity
7 employees
Biotechnology, Health Care

FAQ About Armetheon

San Francisco Bay-based clinical stage biopharmaceutical company dedicated to pioneering novel treatments for urgent medical needs.
Armetheon was founded in 2011.
Armetheon operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Armetheon has approximately 11-50 employees.
Armetheon has completed 2 funding rounds, raising a total of $31.30M. The latest funding stage is Series B.
Top alternatives and competitors to Armetheon include Nuance Biotech Inc, KBP Biosciences, Ampio Pharmaceuticals, Inc., Encysive Pharmaceuticals, IXALTIS SA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Armetheon and Nuance Biotech Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Armetheon and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy